Literature DB >> 25111970

Outcomes in operative management of pancreatic cancer.

Lindsay A Bliss1, Elan R Witkowski, Catherine J Yang, Jennifer F Tseng.   

Abstract

Pancreatic cancer is a highly lethal malignancy that often presents at an advanced stage. Surgical resection can prolong survival and offers the only potential for cure. However, pancreatectomy is associated with significant morbidity and mortality. This article reviews perioperative outcomes, post-resection long-term survival, and innovations in the surgical management of pancreatic cancer.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  outcomes; pancreatectomy; pancreatic cancer

Mesh：

Year:  2014        PMID： 25111970     DOI： 10.1002/jso.23744

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  17 in total

Review 1.  Laparoscopic pancreatic surgery for benign and malignant disease.

Authors:  Thijs de Rooij; Sjors Klompmaker; Mohammad Abu Hilal; Michael L Kendrick; Olivier R Busch; Marc G Besselink
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-17       Impact factor: 46.802

2.  Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.

Authors:  Myrna Hurtado; Umesh T Sankpal; Aboubacar Kaba; Shahela Mahammad; Jaya Chhabra; Deondra T Brown; Raj K Gurung; Alvin A Holder; Jamboor K Vishwanatha; Riyaz Basha
Journal:  Cell Physiol Biochem       Date:  2018-11-30

Review 3.  [Delayed complications after pancreatic surgery: Pancreatic insufficiency, malabsorption syndrome, pancreoprivic diabetes mellitus and pseudocysts].

Authors:  U Nitsche; J Siveke; H Friess; J Kleeff
Journal:  Chirurg       Date:  2015-06       Impact factor: 0.955

4.  Pancreatic cancer stromal biology and therapy.

Authors:  Dacheng Xie; Keping Xie
Journal:  Genes Dis       Date:  2015-06-01

5.  The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration.

Authors:  Vegard Tjomsland; Dagny Sandnes; Ewa Pomianowska; Smiljana Torbica Cizmovic; Monica Aasrum; Ingvild Johnsen Brusevold; Thoralf Christoffersen; Ivar P Gladhaug
Journal:  J Exp Clin Cancer Res       Date:  2016-07-29

6.  Clinical data combined with radiological imaging improves the accuracy of TNM staging of pancreatic body and tail adenocarcinoma.

Authors:  Wei Xu; Bo Jiang; Xinmin Yin
Journal:  Patient Prefer Adherence       Date:  2017-10-04       Impact factor: 2.711

7.  KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control.

Authors:  Florence Le Calvez-Kelm; Matthieu Foll; Magdalena B Wozniak; Tiffany M Delhomme; Geoffroy Durand; Priscilia Chopard; Maroulio Pertesi; Eleonora Fabianova; Zora Adamcakova; Ivana Holcatova; Lenka Foretova; Vladimir Janout; Maxime P Vallee; Sabina Rinaldi; Paul Brennan; James D McKay; Graham B Byrnes; Ghislaine Scelo
Journal:  Oncotarget       Date:  2016-11-29

8.  THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA.

Authors:  Tatiana Falcão Eyff; Henrique Rasia Bosi; Mariana Sandrin Toni; Mariana Blanck Zilio; Carlos Otavio Corso; Vivian Pierri Bersch; Alessandro Bersch Osvaldt
Journal:  Arq Bras Cir Dig       Date:  2018-07-02

Review 9.  Short-term and long term morbidity in robotic pancreatic surgery: a systematic review.

Authors:  Francesco Serra; Isabella Bonaduce; Nicola De Ruvo; Nicola Cautero; Roberta Gelmini
Journal:  Gland Surg       Date:  2021-05

10.  Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma.

Authors:  Hai-Yan Song; Ying Wang; Hong Lan; Yu-Xiang Zhang
Journal:  Exp Ther Med       Date:  2018-05-16       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.